- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02003976
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
December 4, 2023 updated by: Trevor Birmingham, Western University, Canada
The purpose of this study is to compare patients with knee osteoarthritis (OA) receiving optimized non-surgical treatment plus surgical realignment of the tibia, or optimized non-surgical treatment only.
We hypothesize that outcomes assessed at 12 and 24 months follow-up will suggest favourable changes in patients undergoing surgical realignment when compared to patients receiving non-surgical treatment only.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This two groups, parallel design randomized controlled trial will compare patients with medial compartment knee OA and varus alignment receiving optimized non-surgical treatment plus High Tibial Osteotomy (HTO) to similar patients receiving optimized non-surgical treatment only.
All participants will receive non-surgical treatment that will be individualized to the patient and include medications, physiotherapy and nutritional seminars.
The non-surgical treatment will include supervised physiotherapy and nutritional seminars once per week for 12 weeks, will be accompanied and followed by a home program, and follow-up appointments for potential modification every three months for the duration of the study.
Participants randomized to surgery will also undergo medial opening wedge HTO after 12 weeks of optimized non-surgical treatment.
Both groups will follow the same schedule of clinic visits throughout the 24 month follow-up period.
MRI-derived measures of articular cartilage morphology, biological markers of articular cartilage degradation and synthesis, gait biomechanics and patient-reported outcomes will be assessed at baseline, 12 and 24 months follow-up.
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 3K7
- Fowler Kennedy Sport Medicine Clinic, Western University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Is the subject either:
- 25-55 years old?
- Older than 55 but still active (ex. physical labour, regular recreational activities)?
- Does this subject present with varus alignment? (Based on hip to ankle x-rays).
- Does this subject have clinical Knee OA? (MAA <-2° on full limb standing AP) according to the Altman classification primarily involving the medial compartment of the knee?
- Patient is a good candidate for high tibial osteotomy and will be receiving a PEEK plate, or if receiving an alternate plate, agrees to have the plate removed prior to 1 year postoperative.
Exclusion Criteria:
- Has this subject had a previous HTO or joint replacement in either limb?
- Is this subject likely to undergo bilateral HTO within the 2 year follow up period?
- Does this subject have an unstable knee or ligament?
- Does this subject have inflammatory or infectious arthritis of the knee?
- Radiographic disease too advanced for HTO (ie. diffuse lateral compartment, patellofemoral joint OA and/or severe enough disease to suggest that joint replacement is the better surgical option) and/or Kellgren and Lawrence grade 4.
- The subject's disease is not advanced enough (symptomatically or radiographically) to warrant HTO.
- Does this subject have a major medical illness with life expectancy <2 years or with an unacceptably high operative risk?
- Does this subject have a major neurological deficit that would affect gait?
- Is this subject possibly pregnant or planning pregnancy?
- Is this subject unable to read English?
- Does this subject have a psychiatric illness that limits informed consent?
- Is the subject unlikely to comply with study protocol?
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-Surgical Treatment plus HTO
The optimized non-surgical treatment program consists of medications, physiotherapy and nutritional seminars.
The 12-week program will include an assessment by a primary care physician, physiotherapist and orthopaedic surgeon, one supervised physiotherapy session per week, one body recomposition session per week, and a home program.
After the 12-week program is completed, patients randomized to this group will undergo a medial opening wedge high tibial osteotomy (HTO).
They will continue with their home program and will be followed up for 2 years after baseline.
|
A lower limb realignment surgery to redistribute load away from the most affected portion of the knee.
A 12-week optimized non-surgical treatment program consisting of medication, physiotherapy and nutritional seminars.
|
Active Comparator: Non-Surgical Treatment
The optimized non-surgical treatment program consists of medications, physiotherapy and nutritional seminars.
The 12-week program will include an assessment by a primary care physician, physiotherapist and orthopaedic surgeon, one supervised physiotherapy session per week, one body recomposition session per week, and a home program.
After the 12-week program is completed, patients randomized to this group will continue with their home program and will be followed up for 2 years after baseline.
|
A 12-week optimized non-surgical treatment program consisting of medication, physiotherapy and nutritional seminars.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI articular cartilage morphology
Time Frame: Change from baseline to 24 months post operative
|
3 Tesla MRI measure of medial tibiofemoral articular cartilage thickness
|
Change from baseline to 24 months post operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Change from baseline to 24 months post operative
|
Patient-reported outcome measure.
5 subdomains: pain, symptoms, activities of daily living, sport and recreation, quality of life
|
Change from baseline to 24 months post operative
|
Western Ontario Meniscal Evaluation Tool (WOMET)
Time Frame: Change from baseline to 24 months post operative
|
Patient-reported outcome measure.
Assesses health-related quality of life (HRQoL) in patients with meniscal tears.
3 dimensions: physical symptoms, sports/recreation/work/lifestyle, emotions
|
Change from baseline to 24 months post operative
|
Biological Markers of Disease Progression
Time Frame: Baseline, 12 and 24 months post operative
|
Synovial fluid, serum and urine biological markers
|
Baseline, 12 and 24 months post operative
|
Numeric Rating Scale for Pain
Time Frame: Baseline, 12 and 24 months post operative
|
Patient-reported outcome measure.
Assesses patient's pain.
0 (no pain) - 10 (worst possible pain)
|
Baseline, 12 and 24 months post operative
|
Gait Biomechanics
Time Frame: Baseline, 12 and 24 months post operative
|
Knee frontal, sagittal and transverse plane kinematics and kinetics tested during level walking in a motion analysis laboratory.
The measure of most interest is the peak external knee adduction moment during stance phase of walking.
|
Baseline, 12 and 24 months post operative
|
Isometric Strength Testing
Time Frame: Baseline, 12 and 24 months post operative
|
Isometric quadriceps and hamstrings strength tested using an isokinetic dynamometer.
|
Baseline, 12 and 24 months post operative
|
Intermittent and Constant Osteoarthritis Pain Index (ICOAP)
Time Frame: Change from baseline to 24 months post operative
|
Patient-reported outcome measure.
Assesses pain in individuals with hip or knee osteoarthritis taking into account both constant and intermittent pain.
3 domains: intermittent pain, constant pain, total pain
|
Change from baseline to 24 months post operative
|
Short-Form 12 (SF12)
Time Frame: Change from baseline to 24 months post operative
|
Patient-reported outcome measure.
Self-reported outcome measure assessing the impact of health on an individual's everyday life
|
Change from baseline to 24 months post operative
|
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Time Frame: Change from baseline to 24 months post operative
|
Patient-reported outcome measure.
3 sub domains: pain, symptoms, function
|
Change from baseline to 24 months post operative
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost-effectiveness questionnaires
Time Frame: Baseline and every 3 months from baseline up to 24 months post operative
|
Collection of accumulated direct and indirect costs related to the intervention incurred over the study period as reported by the patient.
|
Baseline and every 3 months from baseline up to 24 months post operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Trevor B Birmingham, PT, PhD, Western University
- Principal Investigator: J R Giffin, MD, Western University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 5, 2014
Primary Completion (Actual)
April 18, 2023
Study Completion (Estimated)
April 1, 2024
Study Registration Dates
First Submitted
December 2, 2013
First Submitted That Met QC Criteria
December 2, 2013
First Posted (Estimated)
December 6, 2013
Study Record Updates
Last Update Posted (Actual)
December 5, 2023
Last Update Submitted That Met QC Criteria
December 4, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TAS-SOG-13-020
- MOP-133489 (Other Grant/Funding Number: CIHR)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Medial Opening Wedge High Tibial Osteotomy (HTO)
-
Erasmus Medical CenterCompleted
-
Istituto Ortopedico RizzoliActive, not recruitingKnee Osteoarthritis | Cartilage Degeneration | Malalignment, BoneItaly
-
Mostafa Hassanein, MscCompletedACL Injury | Knee Deformity | ACL - Anterior Cruciate Ligament Deficiency | Varus Deformity of Tibia (Disorder)Egypt
-
University of BathRoyal Devon and Exeter NHS Foundation TrustCompleted
-
University of Campinas, BrazilCompleted
-
Shahid Beheshti University of Medical SciencesCompletedGenu VarumIran, Islamic Republic of
-
Assiut UniversityUnknownOsteo Arthritis Knee
-
Assiut UniversityUnknownOsteo Arthritis KneeEgypt
-
Fowler Kennedy Sport Medicine ClinicCompletedOpening Wedge High Tibial OsteotomyCanada
-
Assiut UniversityNot yet recruiting